title: Intra-operative Use of Hemopatch®: Interim Results of a Nationwide European Survey of Surgeons.
abstract: Haemostasis is a critical part of surgery. Haemostatic agent selection is based upon a number of factors including surgeon's experience and choice. This post-marketing survey determined surgeons' intraoperative use and perception of Hemopatch® (Baxter Healthcare Corporation, Deerfield, IL), a resorbable collagen-based sealing haemostat.
  
  
  
  A one-arm questionnaire was distributed to European general, cardiac, pulmonary, and urologic surgeons who used Hemopatch® to achieve haemostasis in situations where bleeding control by pressure, ligature, or conventional procedures had been ineffective or was impractical. Responses were summarized for patient characteristics, surgical procedures/techniques, and surgeons' assessment of Hemopatch® regarding their overall satisfaction and utilization characteristics of Hemopatch®.
  
  
  
  Of 1028 responses received from seven European countries, the majority were from Germany (47.3%) or Italy (36%). Most cases were in males (60.7%), 50-75 years of age (61.8%), performed by an open approach (82.5%), with 52.7% general-, 16.2% cardiac-, 7.5% lung, 19.5% urologic-type procedures and 3.7% other/unknown. Successful haemostasis after two minutes of approximation occurred in 93.3% of patients (86.8%-96.9% across surgical subtypes), with similar rates by approach (93.1% open; 94.1% minimally-invasive), and patient's use of anticoagulant and/or antiplatelet agents (87.9% - 93.1%). Over 92% of surgeon's rated Hemopatch® as "excellent" or "good" in assessments of overall satisfaction, haemostasis efficacy, ease of preparation, ease of handling, flexibility/pliability, and tissue adherence. These characteristics were rated as excellent or good by 81% or more of surgeons in analyses by surgical subspecialty and surgical approach of open or minimally invasive.
  
  
  
  Hemopatch® provides effective haemostasis across a variety of surgical procedures, both in open- and minimally-invasive, as well as in patients receiving anticoagulant and/or antiplatelet agents. Surgeon's generally rated their overall satisfaction with Hemopatch®, its haemostatic efficacy, and other characteristics as "much better" or "better" than their previously used haemostat.
authors.affiliation: Dept. of General, Visceral, and Oncological Surgery, Wetzlar Hospital and Clinics, Wetzlar, Germany.
authors.forename: Frank
authors.initials: F
authors.lastname: Ulrich
authors.affiliation: Multiorgan Transplantation Program, General Surgery and Transplantation Unit, San Camillo Hospital, Rome, Italy.
authors.forename: Giuseppe Maria
authors.initials: GM
authors.lastname: Ettorre
authors.affiliation: European Hospital, Division of Cardiac Surgery, Rome, Italy.
authors.forename: Luca
authors.initials: L
authors.lastname: Weltert
authors.affiliation: Department of Cardiac Surgery, Asklepios Clinic St. Georg, Hamburg, Germany.
authors.forename: Martin
authors.initials: M
authors.lastname: Oberhoffer
authors.affiliation: Global Medical Affairs, BioSurgery, Baxter Healthcare Corporation, Westlake Village, California.
authors.forename: Huub
authors.initials: H
authors.lastname: Kreuwel
authors.affiliation: Medical Affairs Department, BioSurgery, Baxter SpA, Rome, Italy.
authors.forename: Rafaella
authors.initials: R
authors.lastname: De Santis
authors.affiliation: BioSurgery EMEA, Baxter Healthcare SA, Thurgauerstrasse, Zurich.
authors.forename: Erik
authors.initials: E
authors.lastname: Kuntze
mesh_terms: D000328:Adult; D000368:Aged; D001291:Attitude of Health Personnel; D001458:Bandages; D016063:Blood Loss, Surgical / Q000517:prevention & control* / Q000706:statistics & numerical data*; D004621:Embolization, Therapeutic / Q000295:instrumentation / Q000379:methods / Q000706:statistics & numerical data; D005060:Europe / Q000453:epidemiology; D005260:Female; D019538:Health Care Surveys; D006490:Hemostatics / Q000008:administration & dosage*; D006801:Humans; D007430:Intraoperative Care / Q000295:instrumentation / Q000379:methods / Q000706:statistics & numerical data*; D008297:Male; D008875:Middle Aged; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D015995:Prevalence; D066231:Surgeons / Q000706:statistics & numerical data*; D016896:Treatment Outcome; D014600:Utilization Review; D055815:Young Adult
chemical_list: D006490:Hemostatics